Bambusa Therapeutics, Inc. (BBTX)
Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Bambusa Therapeutics Inc.
No financial data available.
No debt & equity data available.
No splits on record
Nothing in BBTX's public trading history: no forward or reverse split has affected the share count.
No balance sheet details available.
No income statement data available.
No balance sheet data available.
No cash flow data available.